$MKTW

MARKETWISE, INC. (MKTW): Results of Operations and Financial Condition

MARKETWISE, INC. (MKTW) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 earningspressrelease2q2026.htm EX-99.1 Document MarketWise Reports Q2 Billings Increase of 57% YoY to $91.2 Million and Q2 CFFO Increase of 25.7% to $22.4 million; Net Revenue of $75.8 Million and Net Loss of $2.6 Million for Second Quarter 2026; Raises FY 2026 Billings

Original reporting
Published Aug 6, 2026, 12:32 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 1:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$MKTW
Bullish
high confidence
Mentioned
$MKTW
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$MKTWBullishMed
01

Why it matters

Traders can update forward billings expectations and cash-flow assumptions based on the 10% FY 2026 billings guidance increase to $330M, alongside evidence of paid subscriber growth and improved CFFO.

02

Market read

A quantified guidance raise tied to billings growth and cash generation is a direct input to valuation and near-term positioning for MKTW.

03

What to watch

Cash and CFFO strength is partly influenced by working-capital movements and timing of deferred revenue recognition, so investors should watch whether cash conversion sustains in subsequent quarters.

Relevance 7/10Novelty 8/10Timing: filed pre-market today (2026-08-06) with Q2 results and FY 2026 guidance raise

Background

The 8-K (Item 2.02) includes MarketWise’s Q2 2026 operating results, cash-flow metrics, subscriber counts, and updated FY 2026 billings guidance, plus dividend target confirmation.

Company-level read

Ticker impact

$MKTWBullishHigh confidence
Context

MarketWise reported Q2 2026 billings of $91.2M (+57% YoY) and raised FY 2026 billings guidance 10% to $330M.

Expected impact

Likely positive near-term bias as traders reprice FY 2026 billings and cash-flow trajectory.

Evidence & confidence

The filing is a primary disclosure (8-K) with specific Q2 results and a quantified FY 2026 billings guidance increase, which typically drives earnings-model updates and sentiment.

Market effects

Supports the narrative that digital subscription financial research platforms can grow billings while shifting toward margin expansion later in the year.

No clear regional spillover beyond US-listed subscription-services sentiment.

Limited global relevance; primarily impacts US small-cap growth and subscription-services comps.

Counterpoint

GAAP net loss and higher sales and marketing costs indicate the growth phase is still pressuring profitability, so the guidance raise may not translate immediately into earnings power.

Key entities

  • MarketWise, Inc.

    NASDAQ-listed multi-brand digital subscription services platform reporting Q2 2026 results and raising FY 2026 billings guidance.

  • Dr. David Eifrig

    CEO quoted on billings momentum, customer acquisition investment, and expectations for margin improvement in 2H 2026.

Related articles

$KDMed

Kyndryl Q1 Earnings Call Highlights

Kyndryl (NYSE:KD) Q1 call said demand is rising for AI deployment, hybrid modernization, cybersecurity and data-residency. It reported 40 deals worth over $50M in 12 months, with 10 in Q1, and Kyndryl Consult signings up 50%. IBM relationship changes are expected to weigh on constant-currency revenue through FY2027. FCF was -$401M; cash $2.1B. Outlook FY2027 reaffirmed.

$KAIMedAI 8/10

Kadant Q2 Earnings Call Highlights

Kadant (NYSE:KAI) reported Q2 equipment backlog of $182 million and said aftermarket demand stayed at record or near-record levels. Flow Control revenue rose 5% to $100 million; Industrial Processing revenue rose to a record $144 million; Material Handling bookings were $73 million. Q2 gross margin fell to 43.8%. Kadant raised FY revenue guidance to $1.19-$1.21B and adjusted EPS to $12.43-$12.68.

$KRPMed

Kimbell Royalty Q2 Earnings Call Highlights

Kimbell Royalty (NYSE:KRP) reported record Q2 adjusted EBITDA of $84.9 million, with cash G&A of $5.9 million ($2.50 per BOE). It declared a $0.47 per common unit cash distribution, up 15% QoQ, and said 47% may be return of capital. The borrowing base rose to $660 million; debt was $478.7 million. Rig activity and production varied by basin.

$KMPRMed

Kemper Q2 Earnings Call Highlights

Kemper (NYSE:KMPR) reported Q2 results and discussed credit-loss allowances tied to surplus notes in its reciprocal exchange, including a $21 million pre-tax charge on $36 million of notes. Holding-company liquidity was $766 million and debt-to-capital rose to 28.3%. Personal auto normalized combined ratio was 102% and commercial 93.7%, with California rate actions and restructuring savings over $80 million run-rate.

$KOPMed

Koppers Q2 Earnings Call Highlights

Koppers (NYSE:KOP) reported Q2 updates on capital spending of about $24M, shareholder returns of $47M, and debt reduction of $22M in the first half. Liquidity was $390M with net debt of $857M and net leverage at 3.5x. The board raised its dividend to $0.09/share. KOP kept 2026 sales guidance at $1.9B-$2.0B but cut adjusted EBITDA to $240M-$250M and EPS to $3.80-$4.20.